{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae Synergies plus\u2122 Gram-Positive MIC/Combo Panels with Chloramphenicol"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K063564",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "November 27, 2006",
    "Summary Letter Received Date": "December 08, 2006",
    "Submission Date": "November 13, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully automated short-term incubation cycle antimicrobial susceptibility system"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "chloramphenicol"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of gram-positive enterococci and staphylococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan\u00ae Instrumentation",
        "WalkAway\u00ae SI System",
        "Equivalent system"
    ],
    "Method(s)/Technology(ies)": [
        "Broth dilution susceptibility test",
        "Antimicrobial Susceptibility Testing (AST)"
    ],
    "Methodologies": [
        "Minimum Inhibitory Concentration (MIC) determination",
        "Dehydrated panels",
        "Turbidity inoculum preparation"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan\u00ae Synergies plus\u2122 Gram-Positive MIC/Combo Panels with added chloramphenicol antimicrobial agent for susceptibility testing.",
    "Indications for Use Summary": "Determines quantitative and/or qualitative antimicrobial agent susceptibility of colonies of aerobic and facultative anaerobic gram-positive enterococci and staphylococci, with addition of chloramphenicol (4\u201316 \u00b5g/ml) for enterococci and staphylococci.",
    "fda_folder": "Microbiology"
}